Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

October 06, 2015; 85 (14) Clinical/Scientific NotesOpen Access

Electrocortical therapy for motion sickness

Qadeer Arshad, Niccolo Cerchiai, Usman Goga, Yuliya Nigmatullina, R. Ed Roberts, Augusto P. Casani, John F. Golding, Michael A. Gresty, Adolfo M. Bronstein
First published September 4, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001989
Qadeer Arshad
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niccolo Cerchiai
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Usman Goga
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuliya Nigmatullina
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Ed Roberts
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Augusto P. Casani
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Golding
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Gresty
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo M. Bronstein
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Electrocortical therapy for motion sickness
Qadeer Arshad, Niccolo Cerchiai, Usman Goga, Yuliya Nigmatullina, R. Ed Roberts, Augusto P. Casani, John F. Golding, Michael A. Gresty, Adolfo M. Bronstein
Neurology Oct 2015, 85 (14) 1257-1259; DOI: 10.1212/WNL.0000000000001989

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
3264

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Given a sufficiently provocative stimulus, almost everyone can be made motion sick, with approximately one-third experiencing significant symptoms on long bus trips, on ships, or in light aircraft.1,–,4 Current countermeasures are either behavioral or pharmacologic. Behavioral measures include habituation/desensitization treatment protocols5 as well as positioning the head in alignment with the direction of the gravito-inertial force and maintaining a stable horizontal reference frame.5 Pharmacologic measures include antimuscarinics, H1 antihistamines, and sympathomimetics, which all detrimentally impact upon cognitive function, rendering them inappropriate for occupational use.5 All current therapies are only partially effective.

Since a functioning vestibular system is critical to the development of motion sickness,1 we proposed that suppressing vestibular activity could increase tolerance to nauseogenic motion stimuli. We previously showed that application of transcranial direct current stimulation (tDCS), specifically unipolar cathodal stimulation over the left parietal cortex, results in suppression of the vestibular system.6 Herein, we assessed whether such suppression of vestibular activity using tDCS in normal controls may alleviate motion sickness.

Classification of evidence.

This study provides Class II evidence that in normal volunteers undergoing off-axis rotation, left parietal cortex cathodal stimulation increases the time to the development of moderate nausea.

Methods.

We implemented a well-established model of inducing motion sickness termed off-vertical axis rotation (OVAR). Subjects were seated in a motorized chair (NKI; Pittsburgh, PA) with the torso restrained by a 5-point seatbelt with the head, legs, and feet additionally secured with cushioned clamps. The chair was rotated rightwards in the dark, accelerating and tilting gradually over 30 seconds to reach a constant rotational velocity of 72 deg/s, frequency of 0.2 Hz, at a tilt of 18 degrees.7 Twenty right-handed subjects (10 M; 10 F not within 3 days of menstruation) were randomly allocated into 2 age- and sex-matched groups (groups 1 and 2). It was ensured that individuals in both groups were matched for susceptibility to motion sickness as determined by adult-based motion sickness questionnaire scores (MSB scores; see the figure, B for each individual's susceptibility score).8

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Effects of electrocortical stimulation on motion sickness susceptibility

(A) (Left upper panel) Following left cathodal transcranial direct current stimulation (tDCS) stimulation, the susceptibility to motion sickness was reduced, as reflected by the significant increase in off-vertical axis rotation (OVAR) duration required to induce moderate nausea. Also, we observe a significant reduction in the time taken for symptom recovery. In contrast, following left anodal stimulation, we did not observe any significant effects (right upper panel). (B) Adult motion sickness susceptibility scores (MSB) showed significant correlation with the change in OVAR duration (post-pre tDCS) for the left cathodal stimulation only (left lower panel), indicating that less susceptible subjects derived the largest benefit from tDCS. Error bars represent standard errors. *p < 0.05; **p < 0.01.

The experimental design was specifically chosen to test whether tDCS is potentially effective as a prophylactic or abortive treatment. Both groups underwent an initial OVAR session during sham tDCS stimulation only. The time taken to self-report (1) onset of symptoms (i.e., stomach awareness); (2) the primary outcome measure, onset of moderate nausea (i.e., total OVAR duration, with no upper time limit); and (3) subsequent self-recovery were recorded. Subjects were given a 1-hour rest period in a separate room, after which all reported full recovery. Critically, despite recovery, at this time point previous research has shown that subjects have higher motion sickness susceptibility,9 thus allowing us to test the efficacy of tDCS during enhanced susceptibility. After recovery, unipolar tDCS was applied (1.5 mA with a ramp-up and fade-out time of 10 seconds; electrode placement area 25 cm2; for electrode placement on the scalp, we parted the hair and electrodes were held in place with an EEG cap6) with 2 possible different polarities in a double-blind design.6 For group 1 (cathodal) and group 2 (anodal), stimulation was applied initially for 15 minutes immediately prior to the second OVAR session over left parietal cortex and stimulation continued for either a further 15 minutes during the rotation or until subjects reported moderate nausea (i.e., whichever came first). No subjects dropped out or complained of any symptoms associated with either tDCS stimulation or tDCS-mediated vestibular suppression.

Results.

The figure summarizes the results of the experiment. Repeated-measures analysis of variance for cathodal tDCS stimulation with within-subjects factors measurement (OVAR duration, first onset of symptoms, and time to recovery) and condition (before tDCS, after tDCS) showed a significant measurement × condition interaction (F = 9.48, df = 2, p = 0.033; figure, A). Post hoc paired t tests (2-tailed) with Bonferroni corrections showed that following cathodal stimulation, OVAR duration (i.e., time taken for the onset of moderate nausea) was significantly increased (t = 2.68, p < 0.05; figure, A). In contrast, for anodal stimulation, the measurement × condition interaction was not significant. That is, following left cathodal stimulation, it took subjects in the second OVAR session 207 seconds (range 32–382 seconds) longer to develop moderate nausea, whereas following left anodal stimulation subjects developed moderate nausea on average 57 seconds sooner (range 22 to −153 seconds). Notably, those subjects less susceptible to motion sickness (i.e., lower MSB scores) derived the largest benefit following left cathodal tDCS stimulation (r = 0.86, p < 0.001; figure, B). Further, the time taken to recover following cathodal stimulation was significantly reduced (t = 6.0, p < 0.001; figure, A).

Discussion.

Following cathodal tDCS over the left hemisphere, we observed both an increased duration in the time taken to develop moderate nausea during OVAR and a more rapid recovery from symptoms. As no significant effects were observed during anodal stimulation, this excludes the role of both adaptation and nonspecific effects due to tDCS.10 We provide a novel treatment for motion sickness that is, so far, apparently free of side effects.

Footnotes

  • ↵* Q. Arshad and N. Cerchiai contributed equally to this work.

  • Author contributions: Q. Arshad: conceptualized study, acquired data, and wrote the manuscript. N. Cerchiai: conceptualized study and acquired data. U. Goga: acquired data and revised manuscript. Y. Nigmatullina: data analysis and figure preparation. E. Roberts: data analysis and revised manuscript. A. Casani: revised manuscript. J. Golding: conceptualized study, technical expertise, and revised manuscript. M. Gresty: conceptualized study, technical expertise, and wrote manuscript. A Bronstein: conceptualized study, supervised study, and wrote manuscript.

  • Study funding: No targeted funding reported.

  • Disclosure: The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures. The Article Processing Charge was paid by Research Councils-UK (RCUK).

  • Received September 24, 2014.
  • Accepted in final form April 14, 2015.
  • © 2015 American Academy of Neurology

This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. 1.↵
    1. Murdin L,
    2. Chamberlain F,
    3. Cheema S,
    4. et al
    . Motion sickness in migraine and vestibular disorders. J Neurol Neurosurg Psychiatry 2015;86:585–587.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Turner M,
    2. Griffin MJ
    . Motion sickness in public road transport: the effect of driver, route and vehicle. Ergonomics 1999;42:1646–1664.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Turner M,
    2. Griffin MJ,
    3. Holland I
    . Airsickness and aircraft motion during short-haul flights. Aviat Space Environ Med 2000;71:1181–1189.
    OpenUrlPubMed
  4. 4.↵
    1. Lawther A,
    2. Griffin MJ
    . A survey of the occurrence of motion sickness amongst passengers at sea. Aviat Space Environ Med 1988;59:399–406.
    OpenUrlPubMed
  5. 5.↵
    1. Golding JF,
    2. Gresty MA
    . Pathophysiology and treatment of motion sickness. Curr Opin Neurol 2015;28:83–88.
    OpenUrlPubMed
  6. 6.↵
    1. Arshad Q,
    2. Nigmatullina Y,
    3. Roberts RE,
    4. Bhrugubanda V,
    5. Asavarut P,
    6. Bronstein AM
    . Left cathodal trans-cranial direct current stimulation of the parietal cortex leads to an asymmetrical modulation of the vestibular-ocular reflex. Brain Stimul 2014;7:85–91.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Bijveld M,
    2. Bronstein AM,
    3. Golding JF,
    4. Gresty MA
    . Nauseogenicity of off-vertical axis rotation vs. equivalent visual motion. Aviat Space Environ Med 2008;79:661–665.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Golding JF
    . Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998;47:507–516.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Golding JF,
    2. Stott JR
    . Objective and subjective time courses of recovery from motion sickness assessed by repeated motion challenges. J Vestib Res 1997;7:421–428.
    OpenUrlPubMed
  10. 10.↵
    1. Kyriakareli A,
    2. Cousins S,
    3. Pettorossi VE,
    4. Bronstein AM
    . Effect of transcranial direct current stimulation on vestibular-ocular and vestibulo-perceptual thresholds. Neuroreport 2013;24:808–812.
    OpenUrlPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Neurotology

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Review
    Can Transcranial Direct Current Stimulation Enhance Poststroke Motor Recovery?
    Development of a Theoretical Patient-Tailored Model
    Brenton Hordacre, Alana B. McCambridge, Michael C. Ridding et al.
    Neurology, May 13, 2021
  • Article
    Language boosting by transcranial stimulation in progressive supranuclear palsy
    Antoni Valero-Cabré, Clara Sanches, Juliette Godard et al.
    Neurology, July 03, 2019
  • Article
    Cerebello-spinal tDCS in ataxia
    A randomized, double-blind, sham-controlled, crossover trial
    Alberto Benussi, Valentina Dell'Era, Valentina Cantoni et al.
    Neurology, August 22, 2018
  • Article
    tDCS in patients with disorders of consciousness
    Sham-controlled randomized double-blind study
    Aurore Thibaut, Marie-Aurélie Bruno, Didier Ledoux et al.
    Neurology, February 26, 2014
Neurology: 100 (11)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise